Cargando…
A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer’s Disease: Establishment by Using Acitretin as a Model Drug
In the pathogenesis of Alzheimer’s disease (AD) the homeostasis of amyloid precursor protein (APP) processing in the brain is impaired. The expression of the competing proteases ADAM10 (a disintegrin and metalloproteinase 10) and BACE-1 (beta site APP cleaving enzyme 1) is shifted in favor of the A-...
Autores principales: | Freese, Christian, Reinhardt, Sven, Hefner, Gudrun, Unger, Ronald E., Kirkpatrick, C. James, Endres, Kristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946622/ https://www.ncbi.nlm.nih.gov/pubmed/24608847 http://dx.doi.org/10.1371/journal.pone.0091003 |
Ejemplares similares
-
Acitretin reverses early functional network degradation in a mouse model of familial Alzheimer’s disease
por: Rosales Jubal, Eduardo, et al.
Publicado: (2021) -
Shotgun lipidomics of liver and brain tissue of Alzheimer’s disease model mice treated with acitretin
por: Lauer, Anna A., et al.
Publicado: (2021) -
The Synthetic Retinoid Acitretin Increases IL-6 in the Central Nervous System of Alzheimer Disease Model Mice and Human Patients
por: dos Santos Guilherme, Malena, et al.
Publicado: (2019) -
Identification of trichlormethiazide as a Mdr1a/b gene expression enhancer via a dual secretion-based promoter assay
por: Schulze, Sarina, et al.
Publicado: (2015) -
A responsive human triple‐culture model of the air–blood barrier: incorporation of different macrophage phenotypes
por: Kasper, Jennifer Y., et al.
Publicado: (2015)